Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADA
Pharma
Novo's Ozempic 2 mg trumps lower dose on blood sugar reduction
With its semaglutide franchise on a roll, Novo Nordisk has new data showing Ozempic 2 mg tops its lower-dose predecessor on blood sugar reduction.
Fraiser Kansteiner
Jun 26, 2021 4:30pm
Lilly's Trulicity tops Ozempic at keeping patients compliant
Jun 14, 2020 2:54pm
Sanofi boosts Soliqua with real-world data favoring dual therapy
Jun 13, 2020 11:00am
Amid pandemic, ASCO moves online while ADA plows ahead
Mar 25, 2020 2:45pm
